Will Boston Scientific Stock See Higher Levels?

Following a solid performance in Q2, Boston Scientific raised its full year outlook for sales to increase 19-20% and adjusted earnings to be in the range of $1.58-$1.62 per share.

About the Author

has written 23404 stories on this site.

Copyright © 2010 corporatecommunicationsnews101.com